(Q44332725)

2 December 2017

Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans (English)

1 reference

2 December 2017

0 references

0 references

David J Scott

1

1 reference

2 December 2017

Edward F Domino

2

1 reference

2 December 2017

Mary M Heitzeg

3

1 reference

2 December 2017

Robert A Koeppe

4

1 reference

2 December 2017

Lisong Ni

5

1 reference

2 December 2017

Sally Guthrie

6

1 reference

2 December 2017

Jon-Kar Zubieta

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

8 November 2006

1 reference

2 December 2017

Neuropsychopharmacology

1 reference

2 December 2017

32

1 reference

2 December 2017

2

1 reference

2 December 2017

450-457

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301238

2 December 2017

0 references

cites work

Neurobiological mechanisms of the placebo effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Brain metabolic changes during cigarette craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Role of dopamine in the behavioural actions of nicotine related to addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Clinical phenotyping strategies in selection of tobacco smokers for future genotyping studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Assessing the significance of focal activations using their spatial extent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Effect of naloxone on cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Molecular alterations in the neostriatum of human cocaine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

A simple synthesis of [11C]carfentanil using an extraction disk instead of HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Neural activity related to drug craving in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Deficit in attachment behavior in mice lacking the mu-opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Naloxone does not affect cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Is there a common molecular pathway for addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Endogenous opioids and smoking: a review of progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Pain affect encoded in human anterior cingulate but not somatosensory cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Naltrexone, smoking behaviour and cigarette withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Mu-opioid receptor and CREB activation are required for nicotine reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

A three-dimensional statistical analysis for CBF activation studies in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Dopamine transmission in the human striatum during monetary reward tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Serotonin-mediated increases in the extracellular levels of beta-endorphin in the arcuate nucleus and nucleus accumbens: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Regional mu opioid receptor regulation of sensory and affective dimensions of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Naloxone reduces cigarette smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Naloxone alters the local metabolic rate for glucose in discrete brain regions associated with opiate withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Naloxone precipitates nicotine abstinence syndrome in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Regulation of opioid receptors by cocaine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301238

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301238

1 reference

Dimensions Publication ID

2 December 2017

0 references

1 reference